Diabetes, weight management and the next generation of GLP-1
10 March 2026 - 10 March 2026, 7:30 AM - 8:45 PM
Goodfellow Unit is hosting this webinar to review the role of GLP-1 receptor agonists and introduce tirzepatide, a dual GIP/GLP-1 receptor agonist, outlining how its mechanism of action and clinical effects differ from existing GLP-1 therapies.
The webinar will provide practical guidance for primary care clinicians, covering treatment initiation and dose escalation, pen devices and injection technique, storage requirements, and management of missed doses. Common adverse effects and safety considerations across different patient groups, including older adults, will be discussed, with a focus on supporting treatment tolerability and continuity.
Find out more and register.
The webinar will provide practical guidance for primary care clinicians, covering treatment initiation and dose escalation, pen devices and injection technique, storage requirements, and management of missed doses. Common adverse effects and safety considerations across different patient groups, including older adults, will be discussed, with a focus on supporting treatment tolerability and continuity.
Find out more and register.